Managers / Q4 2020 · view latest →
WARBURG PINCUS LLC
CIK 0001162870 · 450 LEXINGTON AVENUE, NEW YORK, NY, 10017 · 212-878-0600
Summary
Warburg Pincus LLC reported $5.8B in U.S.-listed holdings across 10 positions for Q4 2020.
The portfolio is heavily concentrated: SHC alone accounts for 55.9% of reported value.
Compared with Q3 2020, the fund opened 3 new positions and exited 1.
Portfolio Metrics
Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded, with multiple share classes and repeated sub-manager rows for the same issuer combined into one position — the same rule the holdings table uses by default. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.
Reported Value by Quarter
Portfolio Composition
- Common Stock · 71.0% · $4.1B
- Other · 18.7% · $1.1B
- ADR · 10.3% · $602M
Quarter-over-Quarter Changes full breakdown →
vs Q3 2020 (amended baseline)
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| SHCSOTERA HEALTH CO | NEW | +118.93M | 118.93M | +$3.3B | $3.3B |
| YATSEN HLDG LTD | NEW | +44.71M | 44.71M | +$760M | $760M |
| SOC TELEMED INC. | NEW | +33.87M | 33.87M | +$266M | $266M |
| LAREDO PETROLEUM, INC. | SOLD OUT | −2.56M | 0 | −$25M | $0 |
| OMGBPOUTSET MEDICAL INC. | TRIMMED | −4.24M | 4.73M | −$180M | $269M |
| ENDURANCE INTL GROUP HLDGS, INC. | HELD | +0 | 52.56M | +$195M | $497M |
| CANGO INC. | HELD | +0 | 26.72M | +$39M | $187M |
| WEXWEX INC. | HELD | +0 | 577.3K | +$37M | $117M |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q4 2020
| # | Issuer | Class | % Portfolio | Value ↓ | Shares |
|---|---|---|---|---|---|
| 1 | SHCSOTERA HEALTH COhistory → | COM | 55.88% | $3.3B | 118.93M |
| 2 | YATSEN HLDG LTD | ADS | 13.01% | $760M | 44.71M |
| 3 | ENDURANCE INTL GROUP HLDGS, INC. | COM | 8.51% | $497M | 52.56M |
| 4 | ZTOZTO EXPRESS CAYMAN INC.history → | SPONSORED ADS | 7.11% | $415M | 14.23M |
| 5 | OMGBPOUTSET MEDICAL INC.history → | COM | 4.61% | $269M | 4.73M |
| 6 | SOC TELEMED INC. | COM CL A | 4.55% | $266M | 33.87M |
| 7 | CANGO INC. | ADS | 3.20% | $187M | 26.72M |
| 8 | WEXWEX INC.history → | COM | 2.01% | $117M | 577.3K |
| 9 | CYREN, LTD. | SHS | 0.57% | $33M | 32.21M |
| 10 | UXIN LTD | ADS | 0.56% | $33M | 37.40M |
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q1 2026 | $343M | 3 | May 15, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q4 2025 | $984M | 4 | Feb 17, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q3 2025 | $1.3B | 4 | Nov 14, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q2 2025 | $1.2B | 5 | Aug 14, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q1 2025 | $1.3B | 6 | May 15, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q4 2024 | $1.5B | 6 | Feb 14, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q3 2024 | $1.9B | 7 | Nov 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q2 2024 | $1.8B | 7 | Aug 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q1 2024 | $1.8B | 7 | May 15, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q4 2023 | $2.1B | 6 | Feb 23, 2024 | RESTATEMENT | changes · EDGAR ↗ |
| Q3 2023 | $2.8B | 7 | Nov 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q2 2023 | $3.7B | 9 | Aug 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q1 2023 | $3.1B | 9 | May 15, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q4 2022 | $2.2B | 11 | Feb 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q3 2022 | $2.1B | 11 | Nov 14, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q2 2022 | $3.3B | 10 | Aug 15, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q1 2022 | $4.0B | 12 | May 16, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q4 2021 | $3.3B | 10 | Feb 14, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q3 2021 | $4.0B | 11 | Nov 15, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q2 2021 | $4.7B | 12 | Aug 16, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q1 2021 | $4.7B | 11 | May 17, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q4 2020 | $5.8B | 10 | Feb 16, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q3 2020 | $1.5B | 8 | Nov 16, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q2 2020 | $1.1B | 7 | Aug 14, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q1 2020 | $2.7B | 9 | May 14, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q4 2019 | $3.7B | 9 | Feb 14, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q3 2019 | $4.8B | 11 | Nov 13, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q2 2019 | $6.4B | 12 | Aug 14, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q1 2019 | $2.9B | 11 | May 15, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q4 2018 | $3.4B | 12 | Feb 14, 2019 | 13F-HR | changes · EDGAR ↗ |
Other Included Managers
This filing reports holdings on behalf of 1 additional manager.
- Warburg Pincus & Co.28-04826
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.